ABT vs PJT · P/E 25, rev $44.33B vs P/E 30, rev $904.5M
Abbott Laboratories (ABT) versus PJT Partners Inc (PJT) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
PJT Partners Inc (PJT) is a capital markets company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported PJT revenue for 2026-06-30 was $904.5M. Net income was $106.3M. PJT currently screens at market cap $6.72B and trailing P/E 29.6.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. PJT currently screens at market cap $6.72B and trailing P/E 29.6.
Not investment advice. Open the ABT and PJT stock pages for the full models.
Not investment advice.